Semprus BioSciences Corp. landed a $500,000 grant from the National Science Foundation.
The Cambridge, Mass.-based company, which develops vascular access devices, said it will use the NSF's Phase II-B grant to help commercialize its Semprus Sustain Performance products.
Sustain Performance is a coating that reduces bacterial growth and thrombus formation on medical devices and lasts for greater than 90 days, according to the company. If successful, the substance could negate the necessity to coat many implanted medical devices with antimicrobial agents.
The NSF’s grant to Semprus is part of the foundation's Small Business Innovation Research Program. It's the third such grant the company has won since its 2007 founding. Semprus has also been the recipient of funding from the National Institutes of Health, the Dept. of Energy and the Dept. of Defense.
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology
